Zobrazeno 1 - 10
of 672
pro vyhledávání: '"A. Brice"'
Autor:
Abdoulaye Djimde, Seidina A. S. Diakite, Fanta Sogore, Ousmaila Diakite, Brice Campo, Laurent Dembele, Amadou Niangaly, Aboubecrin Sedhigh Haidara, Bintou Diarra, Amadou Daou, Yacouba Bare, Yaw Aniweh, Gordon A. Awandare, Fatoumata I Ballo, Cheick Papa Oumar Sangare, Nouhoum Diallo, Mahamadou Diakite
Publikováno v:
ACS Infectious Diseases. 7:3025-3033
In vitro and ex vivo cultivation of Plasmodium (P) falciparum has facilitated active research into the malaria parasite toward the quest for basic knowledge and the discovery of effective drug treatments. Such a drug discovery program is currently di
Autor:
Bertrand Meda, Edouard Betsem, Lesley McGee, Seydou Yaro, Flavien Aké, Félix Tarbangdo, Berthe Marie Njanpop-Lafourcade, Brice Bicaba, Jennifer C. Moïsi, Cynthia G. Whitney, Srinivasan Velusamy, Alain Gervaix, Lassané Kaboré, Chris A. Van Beneden, Soumeya Ouangraoua, Bradford D Gessner, Tolulope Adebanjo
Publikováno v:
The Journal of Infectious Diseases
Background Burkina Faso, a country in Africa’s meningitis belt, introduced 13-valent pneumococcal conjugate vaccine (PCV13) in October 2013, with 3 primary doses given at 8, 12 and 16 weeks of age. To assess whether the new PCV13 program controlled
Autor:
Martin K. Madsen, Dea S. Stenbæk, Sys Stybe Johansen, Patrick M. Fisher, Albin Arvidsson, Sophia Armand, Kristian Linnet, Gitte Maegaard Knudsen, Brice Ozenne, Maja Rou Marstrand-Joergensen
Publikováno v:
Madsen, M K, Stenbæk, D S, Arvidsson, A, Armand, S, Marstrand-Joergensen, M R, Johansen, S S, Linnet, K, Ozenne, B, Knudsen, G M & Fisher, P M 2021, ' Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience ', European Neuropsychopharmacology, vol. 50, pp. 121-132 . https://doi.org/10.1016/j.euroneuro.2021.06.001
The emerging novel therapeutic psilocybin produces psychedelic effects via engagement of cerebral serotonergic targets by psilocin (active metabolite). The serotonin 2A receptor critically mediates these effects by altering distributed neural process
Autor:
Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine,
Autor:
Brice Ozenne, Drummond E-Wen McCulloch, M.K. Madsen, Patrick M. Fisher, Peter S Jensen, Sara Kristiansen, Dea S. Stenbæk, Gitte M. Knudsen
Publikováno v:
Journal of Psychopharmacology (Oxford, England)
McCulloch, D E-W, Madsen, M K, Stenbaek, D S, Kristiansen, S, Ozenne, B, Jensen, P S, Knudsen, G M & Fisher, P M 2022, ' Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals ', Journal of Psychopharmacology, vol. 36, no. 1, pp. 74-84 . https://doi.org/10.1177/02698811211026454
McCulloch, D E-W, Madsen, M K, Stenbaek, D S, Kristiansen, S, Ozenne, B, Jensen, P S, Knudsen, G M & Fisher, P M 2022, ' Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals ', Journal of Psychopharmacology, vol. 36, no. 1, pp. 74-84 . https://doi.org/10.1177/02698811211026454
BackgroundPsilocybin is a psychedelic drug that has shown lasting positive effects on clinical symptoms and self-reported well-being following a single dose. There has been little research into the long-term effects of psilocybin on brain connectivit
Autor:
Antoine Adenis, Stephanie Clisant Delaine, Ludovic Evesque, Julien Fraisse, Brice Pastor, Marc Ychou, Caroline Mollevi, François Ghiringhelli, Thibault Mazard, Patrick Chalbos
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.564. ⟨10.1186/s12885-021-08312-7⟩
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.564. ⟨10.1186/s12885-021-08312-7⟩
Background The chemotherapy triplet FOLFOXIRI combined to the anti-VEGF antibody bevacizumab is an option in selected patients with metastatic colorectal cancer. In this setting, RAS-mutated metastatic colorectal cancer do not benefit the same from t
Autor:
Amaury Barret, Brice Guerpillon, Camille Vinclair, Laure Alleman, Anne-Christine Jaouen, Heidi Wille, David Leyssene, Marc-Olivier Vareil
Publikováno v:
Infectious Diseases Now. 51:304-307
Objectives To describe the efficacy and safety of prolonged cefazolin course for Staphylococcus infection and the emergence of multidrug-resistant bacteria carriage after treatment. Methods Monocentric retrospective cohort study of patients hospitali
Autor:
Ryan Tang, Jelena Levi, Brice Tiret, Joseph E. Blecha, Henry F. Van Brocklin, Tony Huynh, Myriam M. Chaumeil, Caroline Guglielmetti
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 63, iss 1
Lymphocytes and innate immune cells are key drivers of multiple sclerosis (MS) and are the main target of MS disease modifying therapies (DMT). Ex vivo analyses of MS lesions have revealed cellular heterogeneity and variable T-cell levels, which may
Autor:
Stéphanie Bolle, Cristina Veres, Nadia Haddy, Amel Belhout, Giao Vu-Bezin, Brice Fresneau, Sophie Rivollet, Vincent Souchard, Florent de Vathaire, Neige Journy, Sandrine Haghiri, Christelle Dufour, Chiraz Fayech, Amel Boumaraf, Dominique Valteau-Couanet, Agnès Dumas, Imene Mansouri, Claudia Pasqualini
Publikováno v:
Bone Marrow Transplantation. 56:1984-1997
Intensive treatments including high-dose chemotherapy (HDC) with autologous stem cell rescue have improved high-risk neuroblastoma (HRNB) survival. We report the long-term health status of 145 HRNB survivors, alive and disease-free 5 years post HDC.
Autor:
Anton Hagenbeek, Julia Driessen, Roberto D Liu, Marcel Nijland, Pauline Brice, Wouter J. Plattel, Roelf Valkema, Thomas Gastinne, Harm van Tinteren, Marie José Kersten, Martin Hutchings, Pieternella J. Lugtenburg, Sanne H. Tonino, Daphne de Jong, Arjan Diepstra, Josée M. Zijlstra, Franck Morschhauser, Marta Lopez-Yurda, Coreline N. Burggraaff, Anne I.J. Arens
Publikováno v:
Haematologica, 106(4), 1129-1137. Ferrata Storti Foundation
Haematologica, 106, 1129-1129
Haematologica
Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238
Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION
Haematologica, 106, 4, pp. 1129-1129
Haematologica, 106, 1129-1129
Haematologica
Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238
Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION
Haematologica, 106, 4, pp. 1129-1129
Achieving a metabolic complete response (mCR) before high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplant (auto-PBSCT) predicts progression-free survival (PFS) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL).